Table 2. Clinical characteristics of patients, according to the classification in the molecular subtypes and cellular origin [13].
GCB | ABC | P | |
---|---|---|---|
Gender | |||
Female | 19 (48.7%) | 17 (54.8%) | 0.6108 |
Male | 20 (51.3%) | 14 (45.2%) | |
Age | |||
<60 years | 17 (43.6%) | 15 (48.4%) | 0.6890 |
≥ 60 years | 22 (56.4%) | 16 (51.6%) | |
Ann Arbor Staging | |||
I/II | 17 (43.6%) | 12 (38.7%) | 0.6805 |
III/IV | 22 (56.4%) | 19 (61.3%) | |
IPI | |||
0-1 (low) | 11 (28.2%) | 5 (16.1%) | 0.3994 |
2-3 (intermediate) | 18 (46.1%) | 19 (61.3%) | |
4-5 (high) | 9 (23.1%) | 7 (22.6%) | |
Not assessed | 1 (2.6%) | 0 |